EP1032690A1 - Stressresistenzgen - Google Patents
StressresistenzgenInfo
- Publication number
- EP1032690A1 EP1032690A1 EP98954624A EP98954624A EP1032690A1 EP 1032690 A1 EP1032690 A1 EP 1032690A1 EP 98954624 A EP98954624 A EP 98954624A EP 98954624 A EP98954624 A EP 98954624A EP 1032690 A1 EP1032690 A1 EP 1032690A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- plant
- aldose reductase
- protein
- homologous protein
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 136
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 105
- 150000001323 aldoses Chemical class 0.000 claims abstract description 58
- 238000000034 method Methods 0.000 claims abstract description 32
- 230000035882 stress Effects 0.000 claims abstract description 31
- 230000014509 gene expression Effects 0.000 claims abstract description 27
- 239000013598 vector Substances 0.000 claims abstract description 14
- 230000001965 increasing effect Effects 0.000 claims abstract description 9
- 238000009395 breeding Methods 0.000 claims abstract description 6
- 230000001488 breeding effect Effects 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 230000036579 abiotic stress Effects 0.000 claims abstract description 4
- 230000004790 biotic stress Effects 0.000 claims abstract description 4
- 230000008569 process Effects 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 150
- 241000219823 Medicago Species 0.000 claims description 43
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 39
- 108010053754 Aldehyde reductase Proteins 0.000 claims description 34
- 150000007523 nucleic acids Chemical class 0.000 claims description 27
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 claims description 26
- 108020004707 nucleic acids Proteins 0.000 claims description 25
- 102000039446 nucleic acids Human genes 0.000 claims description 25
- 238000011282 treatment Methods 0.000 claims description 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 22
- 102000016912 Aldehyde Reductase Human genes 0.000 claims description 14
- 150000003254 radicals Chemical class 0.000 claims description 14
- -1 sulphate ions Chemical class 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 7
- 229910001385 heavy metal Inorganic materials 0.000 claims description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 5
- 102000040430 polynucleotide Human genes 0.000 claims description 5
- 239000002157 polynucleotide Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 230000002939 deleterious effect Effects 0.000 claims description 4
- 239000004009 herbicide Substances 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 230000002633 protecting effect Effects 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 229910021653 sulphate ion Inorganic materials 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 abstract description 30
- 230000006378 damage Effects 0.000 abstract description 10
- 230000001603 reducing effect Effects 0.000 abstract description 7
- 230000009931 harmful effect Effects 0.000 abstract description 6
- 238000003306 harvesting Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 45
- 102000004190 Enzymes Human genes 0.000 description 43
- 108090000790 Enzymes Proteins 0.000 description 43
- 229940088598 enzyme Drugs 0.000 description 43
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 42
- 239000002299 complementary DNA Substances 0.000 description 29
- 239000000758 substrate Substances 0.000 description 23
- 238000009396 hybridization Methods 0.000 description 20
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 108020001507 fusion proteins Proteins 0.000 description 12
- 102000037865 fusion proteins Human genes 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 12
- 244000061176 Nicotiana tabacum Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102000005602 Aldo-Keto Reductases Human genes 0.000 description 8
- 108010084469 Aldo-Keto Reductases Proteins 0.000 description 8
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 8
- 229930002875 chlorophyll Natural products 0.000 description 8
- 235000019804 chlorophyll Nutrition 0.000 description 8
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- 229960002163 hydrogen peroxide Drugs 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000000243 photosynthetic effect Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 6
- 125000003172 aldehyde group Chemical group 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000012261 overproduction Methods 0.000 description 5
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 229940044197 ammonium sulfate Drugs 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 229930192334 Auxin Natural products 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002363 auxin Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 230000003412 degenerative effect Effects 0.000 description 3
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 3
- 230000005014 ectopic expression Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 3
- 230000000426 osmoregulatory effect Effects 0.000 description 3
- 230000008723 osmotic stress Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000010624 Medicago sativa Nutrition 0.000 description 2
- 101710197978 NADPH-dependent oxidoreductase Proteins 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000209202 Bromus secalinus Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000718007 Homo sapiens Aldo-keto reductase family 1 member A1 Proteins 0.000 description 1
- 101000836540 Homo sapiens Aldo-keto reductase family 1 member B1 Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101000836455 Rattus norvegicus Aldo-keto reductase family 1 member B1 Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101000836453 Sus scrofa Aldo-keto reductase family 1 member B1 Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000024346 drought recovery Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- UOEFDXYUEPHESS-QMGXLNLGSA-N isopropyl beta-D-galactopyranoside Chemical compound CC(C)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O UOEFDXYUEPHESS-QMGXLNLGSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000019935 photoinhibition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000007279 water homeostasis Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Definitions
- the present invention relates to plant cells, breeding materials, plant parts and plants in which the expression level of the aldose reductase-homologous protein is increased and, therefore, which show higher resistance to stress conditions. Plant cells, breeding materials, plant parts and plants per se are provided and these are advantageously transgenic.
- the present invention further relates to nucleic acid , eg. DNA and RNA molecules .and vectors suitable for providing expression of aldose reductase-homologous protein in cells and processes for the preparation of plant cells overproducing aldose reductase-homologous protein.
- the invention has particular use in reducing damage in crops caused by harmful biotic and abiotic stress conditions and for improving harvest prospects thereby.
- plants are exposed to both abiotic (eg. photoinhibition by high light intensity, UV-B irradiation, ozone, heavy metals, high and low temperature, water deficiency, flooding and wounding) and biotic (eg. viral, bacterial and fungal infections, insect action) stress conditions.
- abiotic eg. photoinhibition by high light intensity, UV-B irradiation, ozone, heavy metals, high and low temperature, water deficiency, flooding and wounding
- biotic eg. viral, bacterial and fungal infections, insect action
- Aldose reductase (EC. 1.1.1.21) and aldehyde reductase (EC. 1.1.1.2.) enzymes belong to the aldo-keto reductase superfamily. These enzymes are monomeric NADPH-dependent oxidoreductases with broad substrate specificity, ranging from aldose sugars to aromatic aldehydes (Bohren K.M. et al. 1989. J. Biol. Chem. 264: 9547-9551). Until now plant aldose reductase enzymes were isolated only from monocots. The expression of the aldose reductase-homologous gene from b? ley is induced in the late period of embryo development (Bartels, D. et al. 1991.
- HNE Because of its reactive ⁇ - ⁇ unsaturated double bond, HNE can spontaneously form Michael adducts with the -SH groups and lysine or histidine residues of cellular proteins.
- the aldehyde group of HNE can form Schiff bases with the ⁇ or ⁇ amino groups of proteins, thus via crosslinking it can alter their catalytic and structural properties. In nanomolar concentrations HNE can cause DNA damage while in higher, eg. micromolar, concentrations it has a cytotoxic effect.
- HNE has an aldehyde group, a possible way of its detoxification is its reduction to alcohol, catalysed by the members of the aldo-keto reductase superfamily.
- the object of the present invention is to produce novel, advantageously transgenic, plant types that, compared to the starting plants, ie. standard crop or ornamental lines, possess an enhanced resistance against both abiotic and biotic stress conditions and to provide a method for producing these.
- the invention is based on the finding that, via overproduction of aldose reductase-homologous enzyme superfamily members having a general detoxificating and osmoregulatory effect, plant cells and plants regenerated from them can be made resistant to a greater extent against number of stress conditions of different origin at the same time.
- the effect of the enzyme is correlated to its ability to reduce aldehyde groups of various substrates, eg. 4-hydroxy-nonenal (HNE) and DL- glyceraldehyde.
- cDNA coding for an alfalfa (Medicago sativa) aldose reductase-homologous enzyme has been isolated by applying recombinant gene manipulation methods. By attaching this cDNA to a regulatory region, eg. a promoter, ensuring ectopic expression in plants, eg.
- overproduction of the aldose reductase-homologous enzyme has been carried out in cells of transgenic plants, thereby enabling the reduction of damage in said plants exposed to stress conditions of different origin via the detoxificating and/or osmoregulatory function of the aldose reductase-homologous protein.
- plants, plant cells, plant parts, breeding material and plant product all of which are advantageously transgenic, which as a consequence of enhanced level of the aldose reductase-homologous enzyme present therein, show an enhanced resistance against the deleterious effects of a number of, and particularly against a wide variety of, stress conditions.
- the invention concerns plant cells that produce one or more aldose reductase-homologous superfamily enzymes capable of reducing aldehyde groups at an enhanced level and, therefore, which posses an enhanced resistance against damaging effects of stress conditions involving the production of free radicals and/or against drought. Particularly provided is resistance against the damaging effects of free radical generation.
- Plant cells, and thus plants, according to the invention advantageously overproduce an aldose reductase-homologous protein comprising the amino acid sequence presented in SEQ ID No 1 , more preferably the alfalfa sequence in SEQ ID No 3 (MsALRh protein) or a functional variant or derivative thereof, said variant being advantageously at least 50% homologous, more advantageously at least 70% homologous and even more advantageously at least 90% homologous to the aldose reductase-homologous protein sequence represented in SEQ ID No 1, and more preferably having such homology to the alfalfa protein of SEQ ID No 3. Still more preferably the cells and plants overproduce such enzymes comprising sequences having at least 50% identity, more preferably at least 70% identity and most preferably at least 90% identity with such sequences, most preferably with SEQ ID No 3.
- Plant cells of the invention are advantageously transgenic and are transformed by incorporation therein of a nucleic acid molecule capable of expressing an aldose reductase-homologous protein.
- Plant cells, plant parts or plants according to the invention can also be produced via traditional non-biological mutation- selection methods wherein, for example, a chemical or UV-light is employed as the mutagenic agent and selection of plants for overproduction of aldose reductase superfamily enzyme of required activity is carried out using assays eg. as described below.
- the level of aldose reductase expression can be determined by hybridisation (using Northern or Western blot techniques, see Example 2) or via detection of the enzymatic activity, particularly that against HNE and/or DL-glyceraldehyde eg. as described below.
- the invention further concerns plants and plant parts comprising plant cells according to the invention.
- Plants and plant parts according to the invention advantageously posses an enhanced level of resistance against stress conditions involving the production of free radicals, more specifically for example against treatments with herbicides and/or heavy metals and/or producing hydrogen peroxide, and/or with NaCl; and/or infections caused by viruses and/or bacteria and/or fungi; and/or drought.
- nucleic acid sequences encoding an aldose reductase-homologous protein for use in the invention as well as recombinant nucleic acid molecules comprising such sequences.
- this nucleic acid is recombinant, isolated, enriched and/or cell free and encodes for the proteins described above having the aforesaid homology to SEQ ID No 1 or 3.
- This provides nucleic acid sequences coding for the aldose reductase-homologous protein, particularly for use in the invention and plant cells of the invention for use in producing plants and plant parts according to the invention.
- nucleic acids of the invention may be designed to encode the functional variants of the reductase proteins of the invention.
- Oligonucleotides and polynucleotides may also be used as probes and primers to identify further naturally occuring or synthetically produced reductase proteins using eg. southern or northern blotting
- the nucleic acid is DNA or RNA, particularly cDNA or cR A and more preferably is characterised in that where it is a DNA it is a polynucleotide comprising nucleotide sequence having at least 80% identity with SEQ ID No 2 as listed in the sequence listing herein, or a sequence having degenerate substitution of codon nucleotides in that sequence, and where it is an RNA it has a complementary sequence wherein T is replaced by U.
- the identity is 90% or more, more preferably 95% or more and most preferably 100%.
- non-identical parts of the sequences comprise degenerate substitutions.
- DNA or RNA is that which is capable of hybridizing with one or both strands of the nucleic acid of SEQ ID No 2, and polynucleotide and oligonucleotide fragments thereof of 15 or more contiguous bases, preferably 30 or more and more preferably 100 or more, selected from a characteristic region of the sequence with respect to nucleic acid encoding for other superfamily enzymes, under high stringency conditions, more preferably being capable of such hybridization with two or more of these polynucleotides or oligonucleotides.
- Most suitable selections of sequences for performing these hybridizations will be selected from coding regions of SEQ ID No 2 coding for parts that are unconserved with respect to the other members of the superfamily.
- amino acids 41 to 49 and 250 to 256 tend to be conserved within the superfamily and thus these sequences as such are unsuitable for use in selecting hybridizing sequences for selecting the preferred homologs of alfalfa type other than in a screen for superfamily members in general.
- nucleic acid encoding for an aldose reductase homologous protein superfamily member, in the form of a vector or contract, combined in frame with a promoter, activating or otherwise regulating sequence capable of promoting its expression ectopically in plants, either constituitively or locally, eg. in vegetative or root tissues.
- this expression is non-temporal, ie.unlike the Rocarati et al promoter, such that the plant tissue is protected from the damaging effects of free-radicals, eg. generation of HNE, at all times.
- tissue specific regulatory regions such as tissue specific promoters
- tissue specific promoters may be used where a specific tissue requires protection from stress related toxins and/or osmoregulation.
- tissue specific promoters will be known to those skilled in the art, but may be exemplified by those of WO 97/20057 (incorporated herein by reference) teaching root specific promoters and those of Rocarti et al, being embryo and seed specific.
- tissue specific promoters may be used but constuitive promoters such as CaMv35S and alfalfa (MsH3gl) (see WO 97/20058 incorporated herein by reference) will have useful application.
- a process for producing plant cells overproducing an aldose reductase-homologous protein which comprises the transformation of a plant cell with a nucleic acid molecule according to the invention.
- a transgenic plant or part thereof comprising recombinant nucleic acid, a vector or construct as described above.
- Preferred plants of the fifth aspect may comprise the nucleic acid of the invention in a construct in functional association with promoter, activating or otherwise regulating sequences.
- Preferred promoters may be tissue specific such that the resultant expression of protein, and thus its effects, are localised to a desired tisssue. Promoters with a degree of tissue specificity will be known to those skilled in the art of plant molecular biology.
- DNA, RNA and vectors containing or encoding for these may be introduced into target cells in known fashion in the field of plant cell transformation. Particularly preferred is the method of introducing the DNA or RNA into cells, more particularly pollen cells, using techniques such as electroporation or gene gun technology.
- tissue specific promoters, enhancers or other activators should be incorporated into the transgenic cells employed in operative relation with the DNA.
- transgenic plant cell or plant may be produced in transgenic form incorporating the nucleic acid of the invention such that aldehyde, particularly HNE, reducing activity in the plant is altered, constituitively or ectopically.
- aldehyde particularly HNE
- reducing activity in the plant is altered, constituitively or ectopically.
- Further aspects of the invention provide alfalfa homologous protein and
- aldose reductase-homologous protein is defined in this description as an enzyme being a member of the aldo-keto reductase superfamily and similarly to other members of this family can reduce the aldehyde group of a wide variety of substrates in the presence of NADPH cofactor.
- aldose reductase-homologous protein as used herein also includes functional variants and derivatives of the said protein.
- a “functional variant” or a “functional derivative” of a protein is a protein the amino acid sequence of which can be derived from the amino acid sequence of the original protein by the substitution, deletion and/or addition of one or more amino acid residues in a way that, in spite of the change in the amino acid sequence, the functional variant retains at least a part of at least one of the biological activities of the original protein that is detectable for a person skilled in the art.
- a functional variant is generally at least 50% homologous (preferably the amino acid sequence is at least 50% identical), advantageously at least 70% homologous and even more advantageously at least 90% homologous to the protein from which it can be derived.
- a functional variant may also be any functional part of a protein; the function in the present case being particularly but not exclusively aldehyde reduction.
- the amino acid sequence differs from SEQ ID No 1 or SEQ ID No
- the protein comprises an amino acid sequence having 90% or more, still more preferably 95%, sequence identity with SEQ ID No 1 or SEQ ID No 3 and optimally 100% identity with those sequences.
- homology and identity percentages can be ascertained using commercially or publically available software packages incorporating, for example, FASTA and BLASTn software or by computer servers on the internet.
- An example of the former is the GCG Wisconsin Software package while both Genbank (see http://www.ncbi.nlm.nih.gov/BLAST) .and EMBL: (see http://www.embl-heidelberg.de/Blast2) offer internet services.
- identity is meant that the stated percentage of the claimed amino acid sequence or base sequence is to be found in the reference sequence in the same relative positions when the sequences are optimally aligned, notwithstanding the fact that the sequences may have deletions or additions in certain positions requiring introduction of gaps to allow alignment of the highest percentage of amino acids or bases.
- sequence are aligned by using 10 or less gaps, ie. the total number of gaps introduced into the two sequences when added together is 10 or less.
- the length of such gaps is not of particular importance as long as the aldehyde reducing activity is retained but generally will be no more than 10, and preferably no more than 5 amino acids, or 30 and preferably no more than 15 bases.
- Preferred parameters for BLAST searches are the default values, ie. for EMBL Advanced Blast2: Blastp Matrix BLOSUMS, Filter default, Echofilter X, Expect 10, Cutoff default, Strand both, Descriptions 50, Alignments 50.
- BLASTn defaults are again preferably used.
- GCG Wisconsin Package defaults are Gap Weight 12, Length weight 4.
- the expression 'degenerative substitution' refers to substitutions of nucleotides by those which result in codons encoding for the same amino acid; such degenerative substitutions being advantageous where the cell or vector expressing the protein is of such different type to the DNA source organism cell that it has different codon preferences for transcription/translation to that of the cDNA source cell. Such degenerative substitutions will thus be host specific.
- the expression 'conservative substitutions' as used with respect to amino acids relates to the substitution of a given amino acid by an amino acid having physicochemical characteristics in the same class.
- an .amino acid in the SEQ ID No 1 or SEQ ID No 3 has a hydrophobic characterising group
- a conservative substitution replaces it by another amino acid also having a hydrophobic characterising group; other such classes are those where the characterising group is hydrophilic, cationic, anionic or contains a thiol or thioether.
- substitutions are well known to those of ordinary skill in the art, i.e. see US 5380712 which is incorporated herein by reference, and are only contemplated where the resultant protein has activity as an aldehyde reducing enzyme, particularly acting upon HNE, eg. in the presence of NADPH.
- a protein or RNA is said to be "produced at enhanced level” or “overproduced” if the concentration of the said protein in the cell where it is produced is at least 20% higher than that in the original cell, ie. a cell of the original plant line which has now been transformed.
- a plant, a plant tissue or a plant cell is defined as having an "enhanced level of resistance" to a harmful condition if it can withstand a 20% enhanced effect of the same harmful condition, without detectable damage, than the original plant, plant tissue or plant cell.
- Overproduction of a molecule in a cell can be achieved via both traditional mutation and selection techniques and genetic manipulation methods.
- ectopic expression is used herein to designate a special realisation of overproduction in the sense that, for example, an ectopically expressed protein is produced at a spatial point of a plant where it is naturally not at all (or not detectably) expressed, that is, said protein is overproduced at said point.
- Particular types of ectopic expression will comprise eg. expression of the aldo-keto reductase protein in vegetative tissues or roots of a plant, whereas normally it may be found only temporally expressed through transcripts in embryo and/or pollen (see Roncarati et al).
- SEQ ID No 1 Amino acid sequence shared by preferred aldose reductase- homologous enzymes to which homology of the enzymes for use in the present invention is related.
- SEQ ID No 2 DNA including cDNA encoding for an alfalfa (Medicago satvia) aldose reductase-homologous enzyme for use in the present invention.
- SEQ ID No 3 Amino acid sequence of an alfalfa (Medicago satvia) aldose reductase homologous enzyme for use in the present invention.
- SEQ ID No 4 .and 5 are those of primers referred to in Example 3.
- FIGURES Figure 1 is a comparison of the amino acid sequence of the alfalfa MsALRh protein to human, animal and plant aldose and aldehyde reductase proteins.
- Figure 2 shows the results of Southern hybridisation of genomic DNA isolated from alfalfa. 20 ⁇ g of genomic DNA was digested with restriction enzymes indicated in the figure below each lane. The restriction fragments were separated on 1% agarose gel and blotted onto Hybond-N membrane. P-32 labelled coding region fragment of the MsALRh CDNA was used as hybridization probe.
- FIG 3 shows the results of Northern hybridisation experiments with the MsALRh cDNA.
- Total RNA was isolated from alfalfa A2 cell suspension treated with 150 ⁇ M ABA (abscisic acid) hormone (3a), 10% polyethylene glycol (PEG 4000, 3b) and cadmium chloride (3c), 20 ⁇ g total RNA was electrophoresed on a 1% formaldehyde-agarose gel and transferred onto Hybond-N membrane, and subsequently probed with P-32 labelled coding region of the MsALRh cDNA fragment. C in each case is untreated control.
- Figure 4 depicts a Western hybridisation analysis of the MsALRh gene expression.
- 4a shows the level of protein in different alfalfa tissues with longer (upper) and shorter expression time.
- 4b shows the change of protein level during 10% PEG, 250 ⁇ M cadmium chloride and ImM hydrogen peroxide treatments.
- Figure 5 is a map of a vector of pGEX origin (pGEX-5X-3) suitable for the expression of the cDNA encoding the enzyme.
- the vector expresses the enzyme as a glutathion-S-transferase fusion protein in E. coli cells.
- Figure 6 shows purification of MsALRh-GST fusion protein on glutathione- Sepharose.
- Figure 7 shows the effect of ammonium sulphate treatment on the activity of the MsALRh-GST recombinant fusion protein.
- Enzymatic activity on lOmM DL- glyceraldehyde substrate was measured spectrophotometrically by determining the measure of NADPH oxidation at 340 run.
- the standard reaction mixture comprised 5 ⁇ g enzyme and 0.15 mM NADPH. Before starting the activity measurement, the enzyme was preincubated with ammonium-sulfate for 3 minutes.
- Figure 8 shows the Western hybridisation detection of the aldose reductase- homologous protein in cell extracts isolated from the leaves of transgenic tobacco plants.
- Figure 9a and 9b show the results of light induced fluorescence measurements of control and transgenic plant leaf discs during 20 ⁇ M paraquat (9a) and 250 ⁇ M cadmium chloride (9b) treatments.
- Figures 10a, 10b, 10c and lOd demonstrate the results of germination tests of control (SRI) and transgenic (1/1, 1/5, 1/9) plants in control 0 conditions (10a), in the presence of 15mM hydrogen peroxide (10b), 150 ⁇ M cadmium chloride (10c) and 250mM sodium chloride (lOd).
- Figure 11 shows results of light induced fluorescence measurements during water deficient growth of control (SRI) and transgenic (TR1/4, 1/7, 1/1, 1/5 and 1/9) plants.
- Figure 12a shows a photograph of control and transgenic plants after 10 days of rehydration after a 35 day severe drought treatment.
- 12b shows detection of the aldose reductase-homologous protein in cell extracts made from leaves of control and transgenic plants shown in 12a after the aforesaid drought tolerance experiment .
- Figure 13 illustrates the photsynthetic efficiency measured as Gentry-parameter of chlorophyll fluorescence in tobacco leaves before (day 1), during (days 2-4) and after (day 8 and day 15) UV-B irradiation.
- Full circles represent average data for plants 1/1, 1/5, 1/8, 1/9 and 1/10.
- Empty circles represent data from plants 1/4 1/7 and control SRI.
- the inventors demonstrate the isolation of a gene encoding an alfalfa (Medicago sativa) aldose reductase-homologous protein, in cDNA form. Its nucleotide sequence and the deduced amino acid sequence verified that the isolated cDNA codes for a novel plant aldose reductase-homologous protein that has not been identified so far.
- the isolated aldose reductase cDNA was cloned into a plant expression vector and by the means of a generally used gene introduction method transformed tobacco plants were produced. Beyond the molecular biological characterization of the transgenic tobacco plants their increased tolerance to different stress conditions has also been shown.
- the alfalfa cDNA library was produced as follows. Total cellular RNA was isolated from in vitro cultivated auxin shock activated alfalfa tissues, which contained dedifferentiated callus tissues and high number of somatic embryos. Stress activation (auxin shock) was performed by using 2,4- dichloro-phenoxyacetic acid (an auxin analog) applying a method known per se so as to enhance the concentration of stress induced mRNAs. The mRNA isolation method applied is detailed in Cathala et al. (1983 DNA 2: 329-335) incorporated herein by reference.
- the mRNA molecules were then separated from the total RNA by the means of oligo-dT cellulose chromathography according to the method of Aviv, H. and Leder, P. (1972 Proc Natl. Acad. Sci. USA 69: 1408-1412) incorporated herein by reference.
- the first cDNA strand was then synthesised on the isolated poly-A + (mRNA) fraction with an oligo-dT primer using AMV reverse transcriptase enzyme. Synthesis of the second DNA strand was done using DNA polymerase I enzyme, removal of the excess of template mRNA was performed via RNase H treatment.
- the nucleotide sequence of about a hundred individual clones of this cDNA library (i.e. cDNA clones prepared from a stress induced mRNA isolate) was determined. Before sequencing, the inserts were subcloned into plasmid pUC 19 and the sequencing reaction was carried out on double stranded DNA using the dideoxy chain termination method with ⁇ -35-S-dATP labelling. For the sequencing reactions the T7 Sequencing Kit (Pharmacia) and Sequenase 2.0 Kit (US Biochem) were used, according to the manufacturers' protocols. Using the determined cDNA sequence, Genebank and ⁇ MBL nucleotide sequence databases were homology searched.
- MsALRh amino acid sequence derived from the clone later designated MsALRh has homology to both human, rat and plant aldo-keto reductase proteins.
- the length of the MsALRh cDNA is 1231 base pairs and the coding region can be located between 34 and 975 nucleotides (S ⁇ Q ID no 2). This region codes for a 313 amino acid protein.
- the amino acid sequence of the alfalfa aldose reductase-homologous protein showed 44.3% identity with the known and best characterised monocot barley aldose reductase-homologous protein and it has 46.2% and 46.1% identity with human aldehyde reductase and pig aldose reductase enzymes, respectively (Fig. 1). It further showed a 42% amino acid identity to the dicotyledonous soybean NADPH-dependent oxidoreductase enzyme. The observed level of amino acid homology led us to conclude that the cloned alfalfa cDNA codes for a novel enzyme of the aldo-keto reductase superfamily.
- Example 2 The amino acid sequence of the alfalfa cDNA codes for a novel enzyme of the aldo-keto reductase superfamily.
- Genomic DNA was isolated from alfalfa cells and the purified DNA was digested with restriction endonucleases.
- the MsALRh cDNA fragment carrying full length coding sequence was used as probe for the Southern hybridisation experiments after radioactive isotope labelling using the "random priming" method (Freinberg, A.P. and Vogelstein, B. 1983. Anal. Biochem. 137: 266-267).
- the hybridisation was carried out in Rapid-hyb buffer (Amersham) at 65°C.
- the result of the hybridisation (Fig. 2) showed that the aldose reductase-homologous gene has a low copy number but faint additional bands on the autoradiogram present at al restriction digestion might indicate the presence of other gene homologues in the alfalfa genome.
- the tissue specificity experiments revealed that the alfalfa aldose reductase-homologous gene is expressed in each tissue in contrary to the barley aldose reductase-homologue, which was expressed only temporally and only in embryos.
- the alfalfa cell suspension was exposed to different hormone and stress treatments. The results indicated that the studied gene is homoinduced.
- Treatment with the plant stress hormone abscisic acid (ABA) significantly enhanced the RNA level 4 hours after its initiation (Fig. 3).
- ABA abscisic acid
- Fig. 3 The importance of this finding lies in the fact that hormone ABA is a key compound in the regulation of several genes that play important role in the adaptation to environmental stresses such as drought and low temperature.
- lipid peroxides Treatment with polyethylene-glycol results in an osmotic stress in plant cells.
- Expression of the MsALRh gene could be induced by such an osmotic stress as well as by cadmium-chloride treatment (heavy metal stress; Fig. 3).
- Cadmium ion is known to induce oxidative stress beside its photosynthetic inhibitory property .and in these cases the level of lipid peroxides increases in the plant cells.
- the decomposition products of the lipid peroxides are those lipid aldehydes that can serve as substrates of the aldo-keto reductases in the detoxification reactions.
- a recombinant protein was produced and purified in a prokaryotic protein expression system.
- the cDNA of the MsALRh gene was cloned into pGEX 4T-1 prokaryotic expression vector (Pharmacia) and the GST (gluthathion-S-transfarase) containing fusion protein was produced in and purified from E. coli.
- the purified fusion protein was raised by conventional techniques. This antibody was used to analyse, by Western hybridization, the effects of different stress treatments on the production of the MsALRh protein and to detect the protein in different tissues of the alfalfa plant (Fig. 4).
- the coding region (975 bp) of the MsALRh cDNA was PCR amplified, using
- primerl (5'-cgaactcgagatggccacagcaatcaagttt-3') as upper and “primer2" (5'- ccgagctctacttcaccatcccagag-3 ' ) as lower primer (Xhol restriction sites in the primers are underlined) according the method of Mullis and Faloona (1987 Meth. Enzymol. 155: 335) incorporated herein by reference.
- the PCR product was digested with Xhol restriction endonuclease and the digested fragment was cloned into the Xhol site of the pGEX 4T-1 vector (Pharmacia). The nucleotide sequence of the cloned product was verified in order to avoid PCR generated errors.
- the transformant E. coli cells were treated with 0.5 mM isopropyl- ⁇ -D-galactopyranoside (IPTG) at 25°C for 3 hours.
- IPTG isopropyl- ⁇ -D-galactopyranoside
- Transformants expressing the fusion protein were identified according to the method of Smith and Johnson (1988 Gene 67: 31-40) incorporated herein by reference.
- the MsALRh-GST fusion protein was purified on glutathione-Sepharose 4B columns following the instructions of the manufacturer's protocol (Pharmacia).
- the produced and purified MsALRh-GST fusion protein (100-150 ⁇ g in 0.5 ml) was thoroughly mixed with the same volume of complete Freund's adjuvant (Sigma) and rabbit was immunised with this emulsion. Two subsequent immunisations were made with the emulsion of the antigen and incomplete Freund's adjuvant after 3 and 6 weeks, respectively.
- the blood serum was checked in Western analysis. The specificity of the serum for the MsALRh protein was tested in a competition experiment. For the Western blot analysis, proteins of the alfalfa cell suspension extracts were separated on a 12% SDS-polyacrylamide gel. After separation, the proteins were transferred onto nitrocellulose membrane.
- the blood serum raised against the fusion protein was used as first antibody (in 1 :2000 dilution); anti-rabbit-IgG antibody conjugated with peroxidase was used as second antibody in these experiments.
- the antigen-antibody complex was detected using Super Signal R TM CL-HRP Substrate System (Pierce), a high sensitivity chemiluminescent detection method.
- Enzymatic activity of the MsALRh-GST fusion protein on different substrates was measured photometrically: measuring the decrease of the concentration of the NADPH cofactor at 340 nm wavelength at 25°C during a 5 minutes reaction time.
- One enzyme activity unit is expressed as the enzyme amount (in mg) which is necessary for the oxidation of 1 ⁇ mol NADPH in one minute in the presence of the substrate.
- Aldose sugars, DL-glyceraldehyde and 4-hydroxy-nonenal (ICN Biochemicals) were used as substrates in these specificity measurements, and the results (as Km kinetic constants) are shown in Tables 1-3 below. According to our results the purified enzyme is able to reduce aldehyde substrates in the presence of NADPH cofactor. High enzymatic activities could only be measured on DL- glyceraldehyde (known as the best substrate for plant aldose reductase-homologues) and on 4-hydroxy-nonenal.
- the MsALRh enzyme could reduce D-xylose with much less activity and showed no activity on other aldose substrates (such as D-glucose, D- galactose, D-mannose or D-ribose) even at very high (400 mM) substrate concentrations.
- alfalfa enzyme showed very similar activity on glyceraldehyde substrate as compared to the animal aldehyde reductases. At the same time, it works less effectively in the presence of 4-hydroxy- nonenal (Table 2).
- HNE 4-hydroxy-nonenal
- the S0 2" ions are known to alter the enzymatic activity of rat aldose and aldehyde reductases in a different manner.
- the resulted twofold increase in the enzymatic activity in the presence of 0.3 M ammonium-sulfate is a characteristic of the aldose reductases (Fig. 7).
- An important property of the MsALRh enzyme is that it's activity increases by 100% even in the presence of low concentration (45 mM) of ammonium-sulfate. This result may indicate that the advantageous effect of the enzyme can be increased in the transgenic plants by ammonium-sulfate treatment.
- MsALRh enzyme as well, as the barley aldose reductase-homologous enzyme, has also similar characteristics to both the animal aldose and aldehyde reductases but it possesses specific different characteristics, too.
- Example 4 Insertion of the alfalfa aldose reductase-homologous (MsALRh) cDNA into tobacco plants to produce the aldose reductase protein in the vegetative organs of transgenic plants
- the produced binary vector construct was mobilized into an Agrobacte ⁇ um strain, tobacco leaves were infected by scratching, co-cultivation was performed and kanamycin resistant plants were regenerated according to Claes et al. (1991.
- the produced binary vector construct was mobilized into an Agrobacte ⁇ um strain, tobacco leaves were infected by scratching, co-cultivation was performed and kanamycin resistant plants were regenerated according to Claes et al. (1991. The
- Plant J. 1: 15-26 incorporated herein by reference. Transformant plants and seeds obtained by self-pollinating were used in the germination experiments.
- aldose reductase gene in the transgenic tobacco plants was verified by Western blot analysis using the polyclonal antibody raised against the MsALR-GST fusion protein. Ten tobacco lines were analysed (Fig. 8). Protein extracts obtained from the leaves of these lines were tested according to the western hybridisation protocol detailed previously except that the protein samples were separated on 10% SDS-polyacrylamide denaturing gel and alkaline phosphatase conjugated anti-IgG antibody was used as second antibody.
- the antibody-protein complex was detected by BCIP (5-bromo-4-chloro-3-indolyl-phosphate) and NBT (2,2'-di-p-nitrophenyl-3,3'-[3,3'-dimethoxi-4,4'-diphenylene]-ditetrazolium-chloride) substrates. Synthesis of considerable amount of the MsALRh protein could be detected in five of the ten examined transgenic lines, the other transgenic lines showed no expression of the MsALRh gene and no signal could be detected in the control wild type (SRI) plant, either.
- BCIP bromo-4-chloro-3-indolyl-phosphate
- NBT 2,2'-di-p-nitrophenyl-3,3'-[3,3'-dimethoxi-4,4'-diphenylene]-ditetrazolium-chloride
- Transformant tobacco plants expressing alfalfa aldose reductase-homologous protein show elevated level of tolerance against different stress treatments, such as herbicide, heavy metal, hydrogen peroxide and sodium chloride
- Transformant tobacco plants were grown in soil under controlled greenhouse conditions for 5 weeks and the water content of the soil was measured at the beginning of the experiment. The damage of the photosynthetic system was monitored during the experiment by light induced fluorescence measurements as detailed in the above experiments. Prior to the beginning of the experiment we have selected plants with similar developmental stage from the transgenic tobacco lines and the SRI control plants and leaves with the same age were chosen on each plant for the fluorescence measurements to be made at given time points during the experiment.
- UV-B irradiation protection UV-B irradiation protection.
- Tobacco plants were kept in a ventilated growth chamber for five test days at 26°C.
- Photosynthetically active radiation was provided from fluorescent tubes (Tungsten 40W) at 60-80 ⁇ mol m "2 s "2 intensity from above and from the side between 8am and 6pm daily.
- UV-B (280-320nm) irradiation was provided from UV-B 313 tubes (Q- panel, USA) at 7.5 ⁇ mol m " s " total UV-B intensity from above between 9am and 3pm daily, for 4 days starting from the second day of the test.
- chlorophyll fluorescence measurement plants were transferred to the laboratory. Measurement was performed in the dark and was completed in ca. 45 minutes including the initial 15 minutes dark adaptation. After this plants were transferred back to the growth chamber or (during the recovery period) to the green house. All chlorophyll fluorescence measurements were performed in the afternoon between ca 3 and 5pm. Untreated plants were measured in the afternoon of the first test day, before starting UV-B irradiation at the second test day. UV-B irradiated plants were measured on the 2 nd -5 th test days, 30 minutes after cessation of irradiation.
- Chlorophyll fluorescence was measured with a PAM Chlorophyll Fluorometer (WALZ Company, Germany) using weak ( ⁇ 1 ⁇ mol m “ s “ ) modulated red light .
- Steady state (F s ) and maximal (F m ') fluorescence yields were measured before and upon a 0.5s saturating white light pulse (2500 ⁇ mol m “ s “ ), respectively, in 11.5 ⁇ mol m "2 s "2 actinic red light.
- Photosynthetic efficiency was measured as the Gentry-parameter of chlorophyll fluorescence in tobacco leaves before (day 1), during (days 2-4) and after (days 8 and
- the isolated alfalfa aldose reductase-homologous gene codes for an enzyme of novel characteristics, which can react with the toxic lipid aldehyde 4- hy droxy-nonenal .
- Transgenic plants expressing the alfalfa aldose reductase-homologous gene were produced to make use of these and other characteristics of the enzyme and the produced plants were proven to be resistant against a wide range of harmful stress treatments.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9702118A HUP9702118A3 (en) | 1997-11-18 | 1997-11-18 | Plants over producing aldose reductase homologous protein can tolerate water deficiency and resist oxidative stresses, and process for producing them |
HU9702118 | 1998-04-21 | ||
PCT/GB1998/003464 WO1999025852A1 (en) | 1997-11-18 | 1998-11-18 | Stress resistance gene |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1032690A1 true EP1032690A1 (de) | 2000-09-06 |
Family
ID=89995761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98954624A Withdrawn EP1032690A1 (de) | 1997-11-18 | 1998-11-18 | Stressresistenzgen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1032690A1 (de) |
JP (1) | JP2001523466A (de) |
KR (1) | KR20010032243A (de) |
CN (1) | CN1292823A (de) |
AR (1) | AR017638A1 (de) |
AU (1) | AU752803B2 (de) |
BR (1) | BR9814644A (de) |
CA (1) | CA2309757A1 (de) |
HU (2) | HUP9702118A3 (de) |
NZ (1) | NZ503443A (de) |
WO (1) | WO1999025852A1 (de) |
ZA (1) | ZA9810540B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4312012B2 (ja) | 2003-09-12 | 2009-08-12 | トヨタ自動車株式会社 | パラコート(登録商標)耐性遺伝子並びに維管束及びトライコーム特異的プロモーター |
CN114015577B (zh) * | 2021-11-03 | 2023-06-30 | 青岛科技大学 | 一种具有镉离子抗逆性的聚球藻株的构建方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2256856T3 (es) * | 1995-04-06 | 2006-07-16 | Seminis Vegetable Seeds, Inc. | Proceso de seccion de celulas transgenicas. |
-
1997
- 1997-11-18 HU HU9702118A patent/HUP9702118A3/hu unknown
-
1998
- 1998-11-18 HU HU0101283A patent/HU226743B1/hu not_active IP Right Cessation
- 1998-11-18 WO PCT/GB1998/003464 patent/WO1999025852A1/en not_active Application Discontinuation
- 1998-11-18 AU AU11675/99A patent/AU752803B2/en not_active Ceased
- 1998-11-18 ZA ZA9810540A patent/ZA9810540B/xx unknown
- 1998-11-18 BR BR9814644-0A patent/BR9814644A/pt not_active IP Right Cessation
- 1998-11-18 CN CN98813179XA patent/CN1292823A/zh active Pending
- 1998-11-18 CA CA002309757A patent/CA2309757A1/en not_active Abandoned
- 1998-11-18 NZ NZ503443A patent/NZ503443A/en unknown
- 1998-11-18 AR ARP980105855A patent/AR017638A1/es not_active Application Discontinuation
- 1998-11-18 KR KR1020007005445A patent/KR20010032243A/ko not_active Application Discontinuation
- 1998-11-18 EP EP98954624A patent/EP1032690A1/de not_active Withdrawn
- 1998-11-18 JP JP2000521215A patent/JP2001523466A/ja active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO9925852A1 * |
Also Published As
Publication number | Publication date |
---|---|
HUP0101283A2 (hu) | 2001-08-28 |
ZA9810540B (en) | 2000-05-18 |
NZ503443A (en) | 2002-03-01 |
HU9702118D0 (en) | 1998-01-28 |
CA2309757A1 (en) | 1999-05-27 |
CN1292823A (zh) | 2001-04-25 |
AR017638A1 (es) | 2001-09-12 |
HU226743B1 (en) | 2009-08-28 |
HUP9702118A3 (en) | 2000-08-28 |
WO1999025852A1 (en) | 1999-05-27 |
HUP9702118A2 (hu) | 1999-07-28 |
BR9814644A (pt) | 2000-10-03 |
AU1167599A (en) | 1999-06-07 |
HUP0101283A3 (en) | 2002-12-28 |
AU752803B2 (en) | 2002-10-03 |
KR20010032243A (ko) | 2001-04-16 |
JP2001523466A (ja) | 2001-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oberschall et al. | A novel aldose/aldehyde reductase protects transgenic plants against lipid peroxidation under chemical and drought stresses | |
US20200113147A1 (en) | Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants | |
Tepperman et al. | Transformed plants with elevated levels of chloroplastic SOD are not more resistant to superoxide toxicity | |
Tran et al. | The polyphenol oxidase gene family in poplar: phylogeny, differential expression and identification of a novel, vacuolar isoform | |
Le Deunff et al. | Oxidative burst and expression of germin/oxo genes during wounding of ryegrass leaf blades: comparison with senescence of leaf sheaths | |
Jung et al. | Dual targeting of Myxococcus xanthus protoporphyrinogen oxidase into chloroplasts and mitochondria and high level oxyfluorfen resistance | |
AU2019466501A9 (en) | Mutant hydroxyphenylpyruvate dioxygenase polypeptide, encoding gene thereof and use thereof | |
Davoine et al. | Specific and constitutive expression of oxalate oxidase during the ageing of leaf sheaths of ryegrass stubble | |
Feng et al. | Cloning and characterization of a novel splicing isoform of the iron-superoxide dismutase gene in rice (Oryza sativa L.) | |
Curtis et al. | Induction of dwarfism in transgenic Solanum dulcamara by over‐expression of a gibberellin 20‐oxidase cDNA from pumpkin | |
CN115044605A (zh) | Lrrk1基因调控水稻抗坏血酸含量和耐盐性的应用 | |
JP4998809B2 (ja) | 植物の鉄欠乏耐性を向上させるポリペプチドおよびその利用 | |
Skinner et al. | Differential expression of genes encoding the light-dependent and light-independent enzymes for protochlorophyllide reduction during development in loblolly pine | |
AU752803B2 (en) | Stress resistance gene | |
US8592649B2 (en) | Functional expression of shuffled yeast nitrate transporter (YNT1) in maize to improve nitrate uptake under low nitrate environment | |
US6545202B2 (en) | Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene | |
CA2211018C (en) | Seed coat specific dna regulatory region and peroxidase | |
US6812338B2 (en) | Peroxisomal ascorbate peroxidase gene induced by high temperature stress and a transgenic plant exhibiting thermotolerance | |
MX2011004216A (es) | Gen at1g67330 novedoso en la eficiencia de captacion de nitrato alterada. | |
クボアキヒロ et al. | Molecular Biological Research on Ascorbate Peroxidase and Glutathione Reductase in the Active Oxygen Scavenging System of Plants: Molecular Cloning and Analysis of Expression in Response to Air Pollutants | |
CN118086332A (zh) | 一种小麦种子休眠基因TaPer12-3A及其应用 | |
Labat et al. | Grapevine (Vitis vinifera L.) alcohol dehydrogenase gene: An important marker of the physiological state during fruit ripening | |
WO1999064613A1 (fr) | Gene de d-ribulose-5-phosphate-3-epimerase de la reponse aux nematodes | |
Ilett | The characterisation of barley and wheat oxalate oxidases expressed in transgenic plants | |
JP2003219883A (ja) | 塩ストレスによって誘導される核酸およびタンパク質 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000505 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HIDEG, EVA Inventor name: SASS, LASZLO Inventor name: FEHER, ATILLA Inventor name: DUDITS, DENES Inventor name: TOEROK, KAROLYNE Inventor name: DEAK, MARIA Inventor name: HORVATH, GABOR Inventor name: OBERSCHALL, ATILLA |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HIDEG, EVA Inventor name: SASS, LASZLO Inventor name: FEHER, ATILLA Inventor name: DUDITS, DENES Inventor name: TOEROK, KAROLYNE Inventor name: DEAK, MARIA M Inventor name: HORVATH, GABOR Inventor name: OBERSCHALL, ATILLA |
|
17Q | First examination report despatched |
Effective date: 20031119 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040330 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1031127 Country of ref document: HK |